Imugene - Charts & Price Action (New thread), page-1540

It's important, at times to also take in fundamental analysis. TA's will get you so far but as other day traders have done is to team up with FA's for a bigger picture.

Here is my FA:

61,000 registered to view the AACR this weekend, with what we don't know to be updated interim analysis or old HERVAXX analysis. On top of this, CF33 commentary to a big crowd of people who really "know their $h1t". Peak volume was 17th November in which 82.4 million shares were traded from a company which has 4.7 billion on issue.

This has a long way to go in my opinion, CF33 IND Approval expected any day now (hopefully) and Hervaxx phase 2 final results with phase 1 final PD1-VAXX before the year's end.

I'm not having a dig at your analysis in any way, just an informed debate. I believe TA and FA can go hand in hand.

That's my take on it, I'm bullish yes, but also a realist.